Arkolith/Insider Trading/CRDF/Form 4

Tannenbaum Renee P

DirectorCardiff Oncology, Inc. (CRDF) · full profile →Form 4 · filed Sep 19, 2022
Net Buying
Open-Market Buys
$17K
Open-Market Sells
$0
Net Open-Market Flow
$17K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2022Buy(P)6K$1.72$11K6K
Sep 15, 2022Buy(P)4K$1.72$6K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-22-025101) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML